Bcl-2 as a Double-edged Sword for the Treatment of Multiple Sclerosis: A Systematic Review. Lashgari N-A, Badrabadi F, Rouhollahi N, Kheirabad S S, Roudsari N M CNS Neurol Disord Drug Targets. 2026 May 22. PMID: 42227475. Abstract CommentRecommendBookmarkWatch
